Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Quadruple Therapy in HIV-HCV Coinfected Null Responders (QUADRIH)
NCT01725542Phase 2Completed
- Sponsor
- ANRS
- Start
- Dec 2012
- Primary completion
- Apr 2014
- Modality
- Small Molecules
- Countries
- 1
01
Overview
A Phase 2 trial of asunaprevir, daclatasvir in hepatitis C (HCV), sponsored by ANRS. Started Dec 2012; status: completed.
02
Drugs
asunaprevirdaclatasvir
03
Conditions
hepatitis C (HCV)
Beyond the preview
Go deeper on NCT01725542.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT01725542.